Adding to the last straw some of my thoughts
Covid revenue declined 83% on PCP (271=>45)
Non Covid (BAU) revenue up 18% on PCP (305=> 258)
Total revenue down 33.9% on PCP (1hfy22) (529=>350)
So I guess maybe we are starting to see some normalization ex covid revenue of around 350m if non-covid side keeps growing at double digit rates.
Not sure what to make of this though - increase in borrowing from FY22 to 65.9m
I was sure that Crescent capital certainly wouldn't offload at $3, but maybe after this 10% spike they will. Think the share price might have overdone itself today.
Was too late adding to the Strawman.
[held]